The obesity epidemic is closely associated with the rising prevalence and severity of
nonalcoholic fatty liver disease (NAFLD): obesity has been linked not only with simple …

The association of obesity with non-alcoholic fatty liver disease (NAFLD) has been
established. Obesity has been linked not only to initial stages of the disease, ie, simple …

The increasing prevalence of nonalcoholic fatty liver disease (NAFLD) parallels the rise of
obesity and its complications. NAFLD is a common cause of cirrhosis and a leading …

Obesity is currently a worldwide epidemic, and will likely only increase in prevalence in the
coming years. The incidence of the metabolic syndrome (MetS) seems to be paralleling …

Non‐alcoholic fatty liver disease (NAFLD), the most common chronic liver disease in the
Western world, is tightly associated with obesity and metabolic syndrome. NAFLD entails an …

The prevalence of non-alcoholic fatty liver disease (NAFLD) is continually increasing due to
the global obesity epidemic. NAFLD comprises a systemic metabolic disease accompanied …

Nonalcoholic fatty liver disease (NAFLD) is now recognized as the most common cause of
chronic liver disease worldwide. Its prevalence has increased to more than 30% of adults in …

Given the increasing prevalence of diabetes and obesity worldwide, the deleterious effects
of non-alcoholic fatty liver disease (NAFLD) are becoming a growing challenge for public …

Abstract Purpose of Review Obesity is closely associated with nonalcoholic fatty liver
disease (NAFLD), a highly prevalent disease without any approved medication. The aim of …

The prevalence of nonalcoholic fatty liver disease (NAFLD) is increasing worldwide.
Globally, it is currently the most common liver disease and is estimated to affect up to 25% of …